Siolta Therapeutics is an early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases. Located in the historic Dogpatch area of San Francisco, we are a part of the innovative incubator program offered by QB3@953.
Location: United States, California, San Francisco
Employees: 11-50
Phone: +1 415-991-0947
Total raised: $42M
Founded date: 2016
Investors 3
Funding Rounds 2
Date | Series | Amount | Investors |
13.03.2024 | Series C | $12M | - |
22.09.2020 | Series B | $30M | - |
Mentions in press and media 6
Date | Title | Description | Source |
13.03.2024 | Siolta Therapeutics Raises $12M in Series C Funding | Siolta Therapeutics, a San Carlos, CA-based clinical-stage biotech company, raised $12M in Series C ... | finsmes.co... |
22.09.2020 | Siolta Therapeutics Raises $30M in Series B Funding | Siolta Therapeutics, a San Carlos, Calif.-based clinical-stage biotech company, raised $30M in serie... | finsmes.co... |
22.09.2020 | Siolta Therapeutics Raises $30M Series B for the Prevention ... | - | mbcbiolabs... |
22.09.2020 | Clinical-Stage Biotech Company Siolta Therapeutics Raises $3... | Clinical-stage biotech company Siolta Therapeutics announced it raised $30 million in Series B fundi... | pulse2.com... |
22.09.2020 | Siolta Therapeutics : Raises $30M Series B for the Preventio... | Siolta Therapeutics, a clinical-stage biotech company, announced today it has raised $30M in a serie... | marketscre... |
- | Siolta Therapeutics | “Siolta Therapeutics is a clinical-stage company developing live biotherapeutics that target the cor... | fastfounde... |